Clinical trial

Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV…

NCT00386230 · Institut de Recherche pour le Developpement, Other · Completed

Key facts

NCT number NCT00386230
Title Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1
Official title Short ZDV Course to Prevent Perinatal HIV in Thailand
Lead sponsor Institut de Recherche pour le Developpement, Other
Collaborators Harvard School of Public Health (HSPH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions HIV Infections, Pregnancy
Intervention type Drug
Interventions ZDV Short (mother)-Short (infant): Comparison of zidovudine durations, ZDV Short (mother)-Long (infant): Comparison of zidovudine durations, ZDV Long (mother)-Short (infant): Comparison of zidovudine durations, ZDV Long (mother)-Long (infant): Comparison of zidovudine durations
Enrollment 1,554
Start date Jun 1, 1997
Completion Aug 1, 2000
First posted Oct 11, 2006
Last update posted May 2, 2008
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies